OMBRE MEN OVERTIME WIPES- benzocaine cloth 
Sambria Pharmaceuticals, LLC

----------

Drug Facts

Active ingredient

Benzocaine USP 7%

Purpose

Male Genital Desensitizer

Indication

For reducing oversensitivity in the male in advance of intercourse,

Warnings

For External Use only. Do not use onbroken or irritated skin.
When using this avoid contact with eyes.
Stop and ask doctor if:

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Apply a small amount to head and shaft of penis before intercourse, or use as directed by a doctor. Wash product off after intercourse. Not suitable for oral use. Use as directed, not for use more than four times per day.

For Questions or Comments, visit our website OMBREMEN.COM

Inactive ingredients

Lactic Acid, Phenol, Phenoxyethanol, Ethylhexylglycerin, Polyethylene Glycol, purified water

Product label

image description

OMBRE MEN OVERTIME WIPES 
benzocaine cloth
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:54723-007
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE7 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
LACTIC ACID, UNSPECIFIED FORM (UNII: 33X04XA5AT)  
PHENOL (UNII: 339NCG44TV)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:54723-007-0110 in 1 PACKAGE01/01/2022
13 mL in 1 PACKET; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01701/01/2022
Labeler - Sambria Pharmaceuticals, LLC (078676259)

Revised: 1/2024
Document Id: 0f25f622-2796-8e14-e063-6394a90a88b6
Set id: 405f23ca-99c1-4db4-aba1-2fd7f93f55ee
Version: 2
Effective Time: 20240117
 
Sambria Pharmaceuticals, LLC